Clinical Trial Update: Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A phase 3 study evaluating sevelamer for secondary hyperparathyroidism in chronic kidney disease has completed, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Sevelamer (sevelamer hydrochloride)

Snippet

Sponsor: Kenneth R. Phelps, M.D. | Conditions: Hyperparathyroidism, Chronic Kidney Disease | Phase 3 | Status: COMPLETED | Results posted: 2014-07-31